Six topics of discussion have been selected based on an extensive consultation process among ESOT’s Sections & Committees. These topics are the focus of the workstreams, managed by leaders in the field, who will connect with peers and mentors. It is our goal to build an expanded network, trigger new research, collaboration, exchange and discussion.
The discussion starts in the workstreams and continues on site at TLJ 2.0 during the Consensus Workshops (WS) on Day 1. The outcomes are shared and presented at the plenary session for open discussion on Day 2.
WS01 – New Surrogate endpoints in transplantation
This workstream focuses on endpoints and “how to define successful kidney transplantation”. The discussion covers innovative organ sources, like xenotransplants, 3D printed organs, lab grown organs, currently not used resuscitated organs using innovative perfusion techniques.
Workstream led and moderated by Maarten Naesens and Stefan Schneeberger
WS02 – CMV infection and disease
This workstream focuses on describing the state of the art of the prevention and treatment of CMV infection in solid organ transplant recipients.
Workstream led by Paolo Antonio Grossi and moderated by Maria Simonenko and Cristina Rovelli
WS03 – Cancer in pre and post transplant patients
This workstream aims to establish a consensus on key questions concerning cancer in solid organ transplant candidates and recipients.
Workstream led by Umberto Maggiore and moderated by Ilaria Gandolfini and Alessandra Palmisano
WS04 – NRP after DCD
This workstream aims to provide an evidence based answer to the following question: Should NRP become standard of care in DCD donation?
Led by Ina Jochmans and moderated by
Maria Irene Bellini
WS05 – Expanding donor pool
This workstream focuses on the changing times as transplant professionals are increasingly confronted with situations in which strict adherence to previous contraindications for solid organ transplantation seems outdated.
Workstream led by Sarwa D. Murad and moderated by Omar Taco
WS06 – HLA desensitization
This workstream focuses on discussing the potential recipients with otherwise suitable donors who are relegated to the ever-expanding deceased-donor waiting list because of preformed human leukocyte antigen (HLA) antibodies (HLA sensitization) which may be acquired via pregnancy, transfusion, and/or prior transplant.
Workstream led by Nizam Mamode and moderated by Edoardo Melilli